Paige Chamberlain
Stock Analyst at Wolfe Research
(1.65)
# 3,315
Out of 4,417 analysts
5
Total ratings
66.7%
Success rate
1.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Paige Chamberlain
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VCYT Veracyte | Rated: Buy | $55 | $51.29 | +7.23% | 1 | Jun 1, 2026 | |
| NTRA Natera | Rated: Buy | $260 | $226.44 | +14.82% | 1 | Jun 1, 2026 | |
| GH Guardant Health | Rated: Buy | $150 | $129.11 | +16.18% | 1 | Jun 1, 2026 | |
| GRAL GRAIL | Initiated Coverage: Hold | n/a | $59.45 | - | 1 | Jun 1, 2026 | |
| TEM Tempus AI | Initiated Coverage: Hold | n/a | $48.79 | - | 1 | Jun 1, 2026 |
Veracyte
Jun 1, 2026
Rated: Buy
Price Target: $55
Current: $51.29
Upside: +7.23%
Natera
Jun 1, 2026
Rated: Buy
Price Target: $260
Current: $226.44
Upside: +14.82%
Guardant Health
Jun 1, 2026
Rated: Buy
Price Target: $150
Current: $129.11
Upside: +16.18%
GRAIL
Jun 1, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $59.45
Upside: -
Tempus AI
Jun 1, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $48.79
Upside: -